Cite
Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
MLA
Nielsen, Malte Hasle, et al. “Hepatoprotective Effects of the Long-Acting Fibroblast Growth Factor 21 Analog PF-05231023 in the GAN Diet-Induced Obese and Biopsy-Confirmed Mouse Model of Nonalcoholic Steatohepatitis.” American Journal of Physiology: Gastrointestinal & Liver Physiology, vol. 324, no. 5, May 2023, pp. G378–88. EBSCOhost, https://doi.org/10.1152/ajpgi.00157.2022.
APA
Nielsen, M. H., Gillum, M. P., Vrang, N., Jelsing, J., Hansen, H. H., Feigh, M., & Oró, D. (2023). Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis. American Journal of Physiology: Gastrointestinal & Liver Physiology, 324(5), G378–G388. https://doi.org/10.1152/ajpgi.00157.2022
Chicago
Nielsen, Malte Hasle, Matthew P. Gillum, Niels Vrang, Jacob Jelsing, Henrik H. Hansen, Michael Feigh, and Denise Oró. 2023. “Hepatoprotective Effects of the Long-Acting Fibroblast Growth Factor 21 Analog PF-05231023 in the GAN Diet-Induced Obese and Biopsy-Confirmed Mouse Model of Nonalcoholic Steatohepatitis.” American Journal of Physiology: Gastrointestinal & Liver Physiology 324 (5): G378–88. doi:10.1152/ajpgi.00157.2022.